My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Sanofi Winthrop Industrie
Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
Today 7:05 EDT
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease
Today 7:00 EDT
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors
October 08, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
September 24, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press release: Availability of the Q3 2025 Aide mémoire
September 24, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1
September 23, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis
September 22, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
September 22, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
September 17, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration
September 11, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes
September 10, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis
September 04, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
August 29, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
August 14, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
August 06, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press release: Online availability of Sanofi’s half-year financial report for 2025
July 31, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range
July 31, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma
July 30, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma
July 25, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline
July 22, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi completes acquisition of Blueprint Medicines
July 18, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi announces extension of Blueprint tender offer
July 17, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
July 16, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press release: Availability of the Q2 2025 Aide mémoire
June 30, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy
June 30, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
June 25, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma
June 23, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
June 20, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press release: Sanofi successfully prices €1.5 billion bond issue
June 17, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
June 15, 2025
From
Sanofi Winthrop Industrie
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.